Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Celerion Receives a Majority Investment from THL Partners

Celerion Receives a Majority Investment from THL Partners

Celerion will receive a majority investment from THL Partners, according to an April 22 press release from THL. The investment will support Celerion’s continued growth, expanding its clinical and bioanalytical capabilities and advancing its work to help pharmaceutical and biotechnology partners bring new therapies to patients worldwide.  Based in Lincoln, Nebraska, Celerion is a clinical research organization that provides comprehensive clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research throughout North America, Europe and Asia. The company was previously acquired by leading global private equity and alternative assets investment... Read More »
BPOC Completes Sale of CDMO Midwest Products & Engineering

BPOC Completes Sale of CDMO Midwest Products & Engineering

Chicago, Illinois-based private equity firm BPOC announced on April 7 that it completed the sale of Midwest Products & Engineering to Graham Partners. Founded in 1978, Midwest Products & Engineering is a contract designer, developer and manufacturer of complex electromechanical and robotic-assisted surgical systems for the medical device market. The company leverages a domestic manufacturing footprint based in Milwaukee and Racine, Wisconsin complemented by global design and supply chain networks.  Based in Newtown Square, Pennsylvania, Graham Partners is a private investment firm specializing in technology-driven companies that drive innovation in advanced... Read More »
BPOC Completes Sale of CDMO Midwest Products & Engineering

PE Firm Ampersand Capital Partners Acquires Purna Pharmaceuticals

On February 12, Massachusetts-headquartered Ampersand Capital Partners announced its acquisition of Purna Pharmaceuticals. Purna Pharmaceuticals is an independent Belgian company established in 1986. The company provides contract services for the development and manufacturing of semi-solid, powders and liquid pharmaceutical products that meet GXP standards as well as specific customer-related requirements. Founded in 1988, Ampersand is a middle-market private equity firm with more than $3 billion of assets under management dedicated to investments in the life sciences and healthcare sectors. As part of Ampersand’s broader life sciences portfolio, the investment creates opportunities for... Read More »
BPOC Completes Sale of CDMO Midwest Products & Engineering

Arcline Investment Management Sells Resolution Medical to Resonetics

Arcline Investment Management, a Nashville, Tennessee-based private equity firm, announced that it has entered into a definitive agreement to sell its portfolio company Resolution Medical to Resonetics. Based in Fridley, Minnesota, Resolution Medical is a scaled, end-to-end engineering services and outsourced manufacturing partner focused on complex Class II and III devices for medical technology markets including structural heart, cardiology and vascular, electrophysiology and neuromodulation therapies. With 240 employees, Resolution Medical provides expertise in device design, prototyping, bio-simulation and product design, through to finished device manufacturing. Founded in 1987,... Read More »
Life Sciences R&D M&A Market Overview: Strategic Buyers Amid a Cooling Market

Life Sciences R&D M&A Market Overview: Strategic Buyers Amid a Cooling Market

Despite a recent cooling in Life Sciences R&D, there has been a shift among buyers towards more selective, strategic acquisitions that prioritize quality over quantity. The Life Sciences R&D sector, encompassing clinical trial management, contract research organization (CRO) services and contract development and manufacturing organization (CDMO) capabilities, plays a central role in biopharmaceutical innovation. These providers help drug developers overcome steep costs, lengthy timelines and regulatory hurdles to deliver new therapies to patients. With biopharma companies under pressure to accelerate pipelines amid rising chronic disease burdens and aging populations, outsourcing... Read More »
The IMA Group Expands Clinical Research Division With Chicago Acquisition

The IMA Group Expands Clinical Research Division With Chicago Acquisition

The IMA Group announced on October 8 the acquisition of Chicago Research Center (CRC), an independent clinical research site based in Chicago, Illinois. Founded in 2005, CRC is known for its expertise in Phase I–IV trials, focused on the central nervous system, sleep disorders, mood and memory disorders, pain and general medicine. The company operates a research sleep lab for dedicated use in insomnia, apnea, narcolepsy, restless leg and shift work sleep disorder clinical trials. The IMA Group provides government workers with medical, psychological and related evaluations, as well as ancillary services, assists payers with case management and occupational health management solutions and... Read More »